Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPFP.L Regulatory News (PFP)

  • There is currently no data for PFP

Directorate Change

27 Jun 2024 07:00

RNS Number : 0511U
Pathfinder Minerals Plc
27 June 2024
 

 

27 June 2024

Pathfinder Minerals plc

("Pathfinder" or the "Company")

 

Directorate Change

 

Pathfinder Minerals PLC (AIM:PFP), an AIM Rule 15 cash shell, announces that Edouard Etienvre has been appointed as independent non-executive director of the Company with immediate effect.

 

Edouard Etienvre is a seasoned executive with over 18 years of experience in the energy and natural resources sectors. Initially in the banking sector (reserve-based lending) and more recently with private and public energy and mining companies, commodities trading houses as well as shipping and infrastructure companies. Edouard has extensive project management, risk assessment, commercial, business development and financing expertise. Edouard holds a MSc in Management from KEDGE Business School.

 

AIM Disclosures

 

Edouard André Denis François Etienvre, aged 41, is, or has been during the last five years, a director or partner of the following companies and partnerships:

 

Current:

Past:

ADX Energy Ltd

Ascent Resources Plc

Danube Petroleum Limited

Kathari Energia Limited

NGX COMMODITIES LTD.

Manticore Resources Ventures Ltd.

Moonshot Ventures Ltd.

Four Trees Energy Limited

Mkushi Resources Ltd.

Bull Petroleum Pty Ltd

SCI Eglantine

SCI Andrew

SCI Edward's

Grekoil Energy Ventures Limited

 

NPK Investments Ltd.

Technipipe Solutions SAS

Technipipe SAS

Quantum Minerals Ventures Ltd

NWP Ventures Ltd.

Manta Oil Company Limited

Manta E&P Investments Ltd

FineGems Extraction Corporation

Energies du Sud S.A.M.

Jagoda Tourmaline Extraction Limited

 

 

 

 

 

Edouard Etienvre does not hold any ordinary shares in the Company.

 

Enquiries:

 

Pathfinder Minerals Plc

Paul Barrett, Executive Director

Tel. +44 (0)20 3143 6748

 

Allenby Capital Limited (Nominated Adviser and Broker)

John Depasquale / Vivek Bhardwaj / Lauren Wright (Corporate Finance)

Stefano Aquilino / Joscelin Pinnington (Sales & Corporate Broking)

Tel. +44 (0)20 3328 5656

 

OAK Securities (Joint Broker)

Jerry Keen, Head of Corporate Broking (jerry.keen@oak-securities.com)

Henry Clarke, Head of Sales (henry.clarke@oak-securities.com)

Tel. +44 (0)20 3973 3678

 

Camarco (Financial PR)

Gordon Poole / Emily Hall / Sam Morris

Tel. +44 (0) 20 3757 4980

 

OAK Securities is a trading name of Merlin Partners LLP. Merlin Partners LLP is authorised and regulated by the Financial Conduct Authority (Reference Number: 449191). Merlin Partners LLP is registered in England and Wales (Registered Partnership Number: OC317265).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAKZGZVLVMGDZM
Date   Source Headline
22nd Feb 20237:00 amRNSUpdate re Sale of IM Minerals
2nd Feb 202311:14 amRNSHolding(s) in Company
1st Feb 20237:01 amRNSUpdate re Bilateral Investment Treaty Claim
1st Feb 20237:00 amRNSPlacing Completion and Total Voting Rights
27th Jan 20235:12 pmRNSResult of General Meeting
9th Jan 20237:00 amRNSNotice of GM
4th Jan 20237:00 amRNSUpdate re Bilateral Investment Treaty Claim
3rd Jan 20237:00 amRNSConditional Placing to Raise £0.5 Million
28th Dec 20223:44 pmRNSUpdate re Loan Agreement
8th Nov 20225:26 pmRNSHolding(s) in Company
30th Sep 20227:00 amRNSHalf-year Results
29th Sep 20227:02 amRNSLoan Agreement
29th Sep 20227:00 amRNSUpdate re Bilateral Investment Treaty Claim
30th Jun 20224:14 pmRNSResult of Annual General Meeting
17th Jun 20224:58 pmRNSNotice of AGM Explanatory Notes
6th Jun 20223:52 pmRNSNotice of AGM
6th Jun 20223:50 pmRNSFinal Results for the Year Ended 31 December 2021
6th May 20223:19 pmRNSExtension of Certain Share Options and Warrants
6th May 20223:10 pmRNSIssue of Equity and TVR
12th Apr 20227:00 amRNSCompany Strategy Update
10th Dec 202111:05 amRNSSecond Price Monitoring Extn
10th Dec 202111:00 amRNSPrice Monitoring Extension
10th Dec 20217:00 amRNSUpdate re Bilateral Investment Treaty Claim
4th Oct 20214:30 pmRNSGrant of Share Options
14th Sep 20217:00 amRNSHalf-year Results
19th Jul 20213:13 pmRNSChange of Registered Office
30th Jun 202111:47 amRNSResult of Annual General Meeting
29th Jun 20217:00 amRNSUpdate re Bilateral Investment Treaty Claim
24th Jun 202111:00 amRNSGrant of Share Options
9th Jun 202110:38 amRNSGrant of Share Options
7th Jun 20217:02 amRNSChange of Adviser
7th Jun 20217:01 amRNSNotice of AGM
7th Jun 20217:00 amRNSFinal Results
27th May 20217:00 amRNSHolding(s) in Company
25th May 20217:00 amRNSDirector Appointment
21st May 20217:00 amRNSUpdate re Bilateral Investment Treaty Claim
12th May 20215:40 pmRNSHolding(s) in Company
12th May 202112:33 pmRNSHolding(s) in Company
4th May 20213:40 pmRNSIssue of Equity and Total Voting Rights
12th Apr 20217:00 amRNSUpdate re Bilateral Investment Treaty Claim
1st Apr 20215:58 pmRNSGrant of Share Options
1st Apr 20215:57 pmRNSHolding(s) in Company
29th Mar 20212:07 pmRNSResult of General Meeting - Replacement
29th Mar 202112:29 pmRNSResult of General Meeting
17th Mar 20217:00 amRNSDirectorate Change
10th Mar 20217:00 amRNSNotice of General Meeting
1st Mar 202110:59 amRNSChange of Auditor
19th Feb 20213:34 pmRNSStrategy Update, Placing, CLN Amendment & TVR
25th Jan 202111:05 amRNSSecond Price Monitoring Extn
25th Jan 202111:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.